亚洲 · 股市与财经 · SCMP Business
China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?
The increasing global appeal of Chinese firms’ novel therapies has propelled the country’s rise as a biomedical powerhouse, but China has yet to produce a drug to rival all-time…
在 SCMP Business 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.scmp.com)



